This text investigates the pharmacological properties, clinical applications, and safety profile of hydroxyethyl starch (HES) within therapeutic settings and blood banking procedures. The authors, John Milton and IV Mishler, synthesize existing clinical data and biochemical research to establish a framework for the appropriate use of synthetic colloids. The work addresses the physiological impact of HES on blood volume expansion and its specific utility in the processing and storage of blood components.

Experts recognize this volume as a specialized reference for clinicians and researchers focused on the historical development of colloid therapy. Readers frequently note the technical density of the prose, which is intended for an audience with a background in hematology or pharmacology.